Search Results
Results found for "Jan Voss"
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
droplets; novel atypical GPCR-arrestin complexes; Lilly's oral GLP-1, orforglipron, delivers weight loss
- The One Reason Why Biotech Startups Fail More Often Than They Should
The illusion of progress and the slow loss of direction One of the most dangerous phases in a biotech
- 📰 GPCR Weekly News, February 12 to 18, 2024
Nayara Braga Emidio, Ross Cheloha, Laura M Wingler, et al. for their work on Nanobody-Mediated Dualsteric
- 📰 GPCR Weekly News, February 20 to 26, 2023
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss
- 📰 GPCR Weekly News, July 1 to 7, 2024
Ross Bathgate, Francisco Olucha-Bordonau, et al. Â
- 📰 GPCR Weekly News, December 11 to 17, 2023
Ross Cheloha's research involves semi-synthetic nanobody-ligand conjugates with enhanced transcriptional
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7 Loss-of-function
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
from November 25th to December 1st, 2024 Industry News Amgen says obesity drug caused up to 20% weight loss
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Scutellaria baicalensis Georgi stems and leaves flavonoids promote neuroregeneration and ameliorate memory loss
